A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.

Correale, P; Messinese, S; Caraglia, M; Marsili, S; Piccolomini, A; Petrioli, R; Ceciarini, F; Micheli, L; Nencini, C; Neri, A; Vuolo, G; Guarnieri, A; Abbruzzese, A; Prete, S D; Giorgi, G; Francini, G

Correale, P; Messinese, S; Caraglia, M; Marsili, S; Piccolomini, A; Petrioli, R; Ceciarini, F; Micheli, L; Nencini, C; Neri, A; Vuolo, G; Guarnieri, A; Abbruzzese, A; Prete, S D; Giorgi, G; Francini, G.

Affiliation

Correale P; Section of Oncology, Human Pathology and Oncology Department, University of Siena School of Medicine, Viale Bracci 11, Siena 53100, Italy.

Br J Cancer ; 90(9): 1710-4, 2004 May 04.

Article de En | MEDLINE | ID: mdl-15150625

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs colorectales / Protocoles de polychimiothérapie antinéoplasique / Désoxycytidine Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Br J Cancer Année: 2004 Type de document: Article Pays d'affiliation: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google